Cell-Based T2R Assays for Bitter Taste Modulation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
There is a need for a greater understanding of the specific ligands that activate human T2R receptors, as existing technologies have limitations in identifying compounds that modulate bitter taste perception effectively, particularly for receptors like hT2R8, hT2R54, and hT2R75, which are involved in bitter taste responses.
Innovation Solution
The discovery that hT2R8, hT2R54, and hT2R75 are specifically activated by ranitidine, hT2R54 by acetaminophen, and hT2R8, hT2R10, hT2R13, hT2R54, and hT2R75 by denatonium benzoate, with the use of cell-based assays to identify compounds that block these activations, enabling the modulation of bitter taste in foods and beverages.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If cell-based assays are used to identify compounds that block bitter taste receptors, then the precision of identifying specific ligand-receptor interactions is improved, but the complexity of the assay system increases
Solution Approach 1:
The patent uses G-protein coupled signaling pathways as intermediaries to translate receptor-ligand binding events into measurable cellular responses. The assay system employs intermediary molecules such as calcium indicators and cAMP reporters that convert specific receptor activation into quantifiable signals, thereby maintaining measurement precision while managing system complexity through established biochemical cascades.
Solution Approach 2:
The invention creates simplified copy models of the bitter taste receptor system by expressing human T2R receptors in heterologous cell lines. This copying approach allows the complex human taste receptor system to be replicated in a controlled assay environment, enabling precise identification of ligand-receptor interactions without requiring native taste tissue, thus reducing overall system complexity while maintaining functional accuracy.
2Loss of information
If multiple T2R receptors are tested with various compounds to identify specific activators, then the completeness of bitter taste mechanism understanding is improved, but the time required for screening increases
Solution Approach 1:
The patent performs preliminary characterization of individual T2R receptors by identifying their specific ligand preferences before conducting comprehensive screens. By pre-establishing which receptors respond to which classes of bitter compounds (e.g., hT2R8 responds to ranitidine, hT2R54 to acetaminophen), the system creates a knowledge framework that guides subsequent screening efforts, reducing redundant testing and accelerating the overall identification process while maintaining completeness.
Solution Approach 2:
The invention segments the comprehensive bitter taste screening into receptor-specific modules, where each T2R receptor is evaluated independently with targeted compound libraries. This segmentation allows parallel processing of multiple receptor- ligand pairs, reducing the sequential time required for screening while ensuring that no receptor-ligand interaction is missed, thereby maintaining completeness of the bitter taste mechanism understanding.
3Reliability
If specific T2R receptors are targeted with modulator compounds, then the effectiveness of bitter taste modulation is improved, but the difficulty of identifying effective modulators increases
Solution Approach 1:
The patent employs colorimetric and fluorescent indicators that change optical properties in response to intracellular signaling changes caused by T2R activation. These optical changes provide direct, visual measurement of receptor modulation effectiveness, transforming the difficult-to-detect molecular events of bitter taste modulation into easily measurable optical signals that indicate whether a compound effectively modulates specific T2R receptors.
Solution Approach 2:
The invention replaces direct measurement of bitter taste perception (a complex physiological response) with biochemical surrogate measurements of receptor activation. By substituting the mechanical/physiological measurement system with biochemical assays that detect second messenger changes (cAMP, calcium), the system simplifies the detection and measurement of modulator effectiveness while maintaining reliability of the results.
Data Source
AI summary
The present invention relates to the discovery that specific human taste receptors in the T2R taste receptor family respond to particular bitter ligands, i.e., acetaminophen, ranitidine, strychnine and denatonium. The present invention further relates to the use of these receptors in assays for identifying ligands that modulate the activation of these taste receptors and which may be used as additives in foods, beverages and medicinals for modifying (blocking) T2R-associated bitter taste.